1. "Journal of Clinical Oncology"
  2. "Paul Meyers"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (25)
Groups
  1. Pediatrics, Department of (55)
  2. Sarcoma Service (Pediatrics) (55)
  3. Surgery (17)
  4. Orthopaedic Service (15)
  5. Center for Hematologic Malignancies (14)
  6. Pediatric Leukemia (12)

More Groups

People
  1. Paul Meyers (55)
  2. John Healey (14)
  3. Leonard Wexler (11)
  4. Andrew Huvos (8)
  5. Richard Gorlick (7)
  6. Glenn Heller (6)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2018 (1)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (55)
Publishers
  1. American Society of Clinical Oncology (55)

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
    Meeting Abstract

    Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Gundem, G.; Ossa, J. E. A.; Bouvier, N.; Dela Cruz, F. S.; Hameed, M.; Bender, J. L. G.; Tap, W. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results
    Meeting Abstract

    Ludwig, J. A.; Federman, N. C.; Anderson, P. M.; Macy, M. E.; Riedel, R. F.; Davis, L. E.; Daw, N. C.; Wulff, J.; Kim, A.; Ratan, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing sarcoma (ES) and select sarcomas
    Meeting Abstract

    Reed, D. R.; Chawla, S. P.; Setty, B.; Mascarenhas, L.; Meyers, P. A.; Metts, J.; Harrison, D. J.; Lessnick, S. L.; Crompton, B. D.; Loeb, D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase 1 trial of seclidemstat (SP-2577) in patients with relapsed/refractory Ewing sarcoma
    Meeting Abstract

    Reed, D. R.; Chawla, S. P.; Setty, B.; Mascarenhas, L.; Meyers, P. A.; Metts, J.; Harrison, D. J.; Loeb, D.; Crompton, B. D.; Wages, D. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma
    Meeting Abstract

    Reed, D. R.; Mascarenhas, L.; Meyers, P. A.; Chawla, S. P.; Harrison, D. J.; Setty, B.; Metts, J.; Wages, D. S.; Stenehjem, D. D.; Santiesteban, D. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • OSTPDL1: A phase II study of avelumab, a monoclonal antibody targeting programmed death-ligand 1 (PD-L1) in adolescent and young adult patients with recurrent or progressive osteosarcoma
    Meeting Abstract

    Bishop, M. W.; Kaste, S. C.; Sykes, A.; Pan, H.; Dela Cruz, F. S.; Whittle, S.; Mascarenhas, L.; Thomas, P. G.; Youngblood, B.; Harman, J. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES)
    Meeting Abstract

    Meyers, P. A.; Ambati, S. R.; Slotkin, E. K.; Dela Cruz, F.; Wexler, L. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Off-label use of bevacizumab in relapsed and refractory pediatric sarcoma patients: The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Slotkin, E. K.; Magnan, H. D.; Meyers, P. A.; Chou, A. J.; Ambati, S. R.; Wexler, L. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save